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 PURPOSE: To compare two therapeutic modalities on
natomic and functional results after idiopathic macular
ole (MH) surgery: seated vs face-down position.
 DESIGN: Multicenter, prospective, randomized trial.
 METHODS: SETTING: University Hospital Dijon and
niversity Hospital Nancy. PATIENTS: One hundred
nd forty-four patients (150 eyes) were enrolled and
andomly separated into two groups for postoperative
osition: for the 72 eyes in the P0 group and the 78
yes in the P1 group, the patients were asked to keep
he seated (P0 group) and the face-down position (P1
roup) after the idiopathic MH surgery. INTERVENTION:
ll patients underwent a complete vitrectomy with a
uid-air exchange and an intraocular gas tamponade.
fter the surgery, patients were asked to keep one of
he two randomly chosen positions for five days. MAIN
UTCOME MEASURES: Best-corrected visual acuity (VA),
undus examination, and macular optical coherence
omography were performed before and six months
fter surgery.
 RESULTS: The overall anatomic success rate was
2.7%. The idiopathic MH sealed in 63 of 72 P0 eyes
87.5%) and 76 of 78 P1 eyes (97.4%) (P  .027).
he mean VA increased from 0.86 to 0.61 logMAR
0.88 to 0.61 in P0 and 0.84 to 0.60 in P1). However,
n a post hoc analysis based on the size of the idiopathic
H, the success rate in idiopathic MHs smaller than
00  m was not influenced by the postoperative
osition (P  .47).
 CONCLUSIONS: A face-down postoperative position
s highly recommended in holes larger than 400  m.
he size of the idiopathic MH seems to be an impor-
ant factor affecting outcome. (Am J Ophthalmol
008;146:128 –134. © 2008 by Elsevier Inc. All
ights reserved.)
Supplemental Material available at AJO.com.
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© 2008 BY ELSEVIER INC. A28INCE 1991, STAGE 2, 3, AND 4 IDIOPATHIC MACULAR
holes (MHs)1 have benefited from an effective
treatment as described by Kelly and Wendel:2 pars
lana vitrectomy, removal of adherent cortical vitreous,
tripping of epiretinal membranes, total gas-fluid ex-
hange, and intraocular tamponade with a nonexpan-
ive gas (sulfur hexafluoride gas [SF6]), with occiput-up
ostoperative positioning for one week. Closure is now
btained in a large proportion of cases.3
Modifications have been proposed to increase the rate
f closure: different gases were used (SF6; hexafluoro-
thane [C2F6]; octafluoropropane [C3F8])4 for intraoc-
lar tamponade, internal limiting membrane (ILM)
eeling was proposed with or without dye,5–7 and the
fficacy of adjuvant treatments such as transforming
rowth factor (TGF)- , 8 –10 autologous platelets,11–13
nd autologous serum were analyzed.14 The complica-
ion rate is relatively low and recent attempts have been
ade to simplify the surgical technique using transcon-
unctival sutureless surgery.15–17
However, postoperative face-down positioning after
diopathic MH surgery remains a limiting factor because
f obesity, old age, arthritis, and other causes of mobility
oss. The duration of positioning and the restrictions
nherent to the position remain real problems for
atients living alone. The face-down position can also
ncrease the immobilization period, leading to thrombo-
is, embolism, and neurologic complications.18,19 Some
uthors have suggested using silicone oil to avoid these
ositioning problems.20 –22 However, since the success
ate with silicone oil was not as good as it was with gas,
ilicone oil has been largely abandoned.
The very good prognosis for small MHs and the
orbidity of occiput-up positioning for one week led
ome authors to stop postoperative positioning, showing
ncouraging results.23,24 To the best of our knowledge,
here has been no comparative, randomized trial evalu-
ting the influence of face-down positioning after MH
urgery on the anatomic and functional results vs no
ositioning at all. We undertook this study to compare
he usual face-down position with a seated position. The
omfortable seated position was chosen to prevent the
atient from looking up after MH surgery.
































































 PROSPECTIVE, INTERVENTIONAL, COMPARATIVE AND
andomized clinical trial was conducted in 150 eyes of
44 consecutive patients undergoing MH surgery in two
cademic centers between July 1, 2004 and January 31,
006. Patients had complete information about the
tudy and the risks of the surgical procedure, especially
etinal detachment (RD), and gave their written con-
ent before surgery.
Patients with stage 2, 3, and 4 idiopathic MHs
ccording to Gass1 and confirmed by optical coherence
omography (OCT) were included. Exclusion criteria
ere an axial length longer than 27 mm, a previous
acular surgical procedure, stage 1 MHs, posttraumatic
r other secondary MHs, and inability to assume a
orrect face-down position.
Symptom duration was recorded and visual acuity
VA) was measured with projected-light Snellen charts
onverted to logarithm of minimal angle of resolution
logMAR). A complete ocular examination was per-
ormed in each patient, including anterior segment
valuation, intraocular pressure (IOP) measurement,
undus, careful peripheral retina examination, axial
ength measurement, and macular OCT (Stratus OCT
II; Carl Zeiss Meditec, Dublin, California, USA),
efore and three and six months after the surgical
rocedure. The largest diameter of the idiopathic MH
as measured with OCT (Figure 1).
All patients underwent the same surgical procedure: an
xtensive three-port pars plana vitrectomy using 20-gauge
nstrumentation. A peristaltic or venturi pump was used
ith maximum vacuum set between 200 and 500 mm Hg
ccording to the surgeon’s preference, to obtain posterior
itreous detachment. The posterior hyaloid was generally
ttached to the disk (stage 2 and 3) and the macula (stage
) and was lifted either with the vitreous cutter probe or
ith an active suction through a blunt cannula. Then the
LM was systematically removed using microforceps with-
ut indocyanine green or any other dye. Vitrectomy was
IGURE 1. Optical coherence tomography (OCT) of a macu-
ar hole (MH) and the measure of its size using calipers. Six
adial scans were performed and the largest diameter was
ecorded for analysis.ompleted, especially at the vitreous base. The retinal o
POSITIONING AFTER MACUOL. 146, NO. 1eriphery was carefully examined. Finally, total fluid-air
xchange (FAE) was performed and a nonexpanding
ixture of air and SF6 (20%) was used for pneumatic
amponade in idiopathic MHs less than 500 m, air and
2F6 (17%) in idiopathic MHs larger than 500 m, and
ir and C3F8 (14%) in idiopathic MHs larger than 800
m. Combined phacoemulsification could be done with
osterior chamber intraocular implantation when needed.
ll surgeries were performed under peribulbar anesthesia.
atients were randomized following completion of the
urgery into two groups: P0 and P1. After surgery, the P0
roup patients were asked to keep a seated position and P1
atients a strict face-down position eight hours a day
ntermittently while awake for five days (see Supplemental
igure at AJO.com). Intensive recommendations were
iven to the patients prior to their return home to ensure
hat the correct position was adopted. If the patients could
ot maintain the position at home, then they were
ccommodated in a convalescent home. In all cases,
atients were asked not to look up. If the MH was still
TABLE 1. Patient Characteristics Before Idiopathic
Macular Hole Surgery: The Idiopathic Macular Hole Stage





Eyes, n (%) 150 (100%) 72 (48%) 78 (52%)
Male, n (%) 52 (35%) 25 (48%) 27 (52%)
Female, n (%) 98 (65%) 47 (48%) 51 (52%)
Age, mean ( SD) 69 ( 9.5) 68 ( 9.6) 69 ( 9.4)
OCT MH size
400 m, n (%) 70 (47%) 33 (47%) 37 (53%)
400 m, n (%) 80 (53%) 39 (49%) 41 (51%)
MH clinical stage
2, n (%) 14 (9%) 5 (36%) 9 (64%)
3, n( %) 112 (75%) 56 (50%) 56 (56%)
4, n (%) 24 (16%) 11 (46%) 13 (54%)
MH  macular hole; OCT  optical coherence tomography.
TABLE 2. Intraocular Gas Used During the Surgery was
Dependent of Idiopathic Macular Hole Size: Anatomic










0-500 m 57 1 42 3 103 SF6 20%
500-800 m 17 1 19 5 42 C2F6 17%
800-1000 m 2 0 2 1 5 C3F8 14%
P0  seated position; P1  face-down position.pen at the one-month postoperative visit, the patient had

































nother surgical procedure followed by adoption of the
lassical face-down postoperative position.
The primary endpoint was anatomic closure of the hole
fter one surgical procedure confirmed by OCT. The
econdary endpoint was best-corrected VA change be-
ween the preoperative and the six-month visit. The VA
esults were analyzed according to the surgical procedure:
ith or without combined phacoemulsification. A second-
ry analysis was performed considering the size of the
diopathic MH determined by OCT: MHs were separated
nto two subgroups, small MHs (400 m) and large ones
400 m). Data were analyzed using the Fisher exact
est, the paired t test, and the Mann–Whitney U test. The
IGURE 2. Idiopathic MH surgery success rates according to
he position. Face-down position got better anatomic results.
1: face-down position; P0: seated position. Fisher exact test;
 .027.
IGURE 3. Idiopathic MH surgery success rates for holes
maller than 400 m according to the postoperative position.
here was no significant difference between the two positions.
1: face-down position; P0: seated position. Fisher exact test;
 .47.hreshold of statistical significance was set at P  .05. T
AMERICAN JOURNAL OF30RESULTS
NE HUNDRED AND FIFTY EYES WERE INCLUDED IN THIS
rospective series; patient characteristics are given in
able 1. The intraocular gases used are given in Table 2.
IGURE 4. Anatomic results of all the idiopathic MH surger-
es according to initial size of the holes.
IGURE 5. Idiopathic MH surgery success rate according to
nitial size of the hole and postoperative position. Seated
ostoperative position success rates decrease for holes larger



















































































onths; range, six to 25). Overall, 92.7% of the MHs were
losed with one operation (139 anatomic successes out of
50 idiopathic MH surgeries). For the P0 group, the
natomic success rate was 87.5% (63/72) vs 97.4% (76/78)
or the P1 group. The difference between P0 and P1 was
ignificant (P  .027) (Figure 2). Mean VA increased from
.86 to 0.61 logMAR (P  .001). The mean VA improved
rom 0.88 to 0.61 (P  .006) and from 0.84 to 0.60 (P 
027) in the P0 and P1 groups, respectively. There was no
ignificant difference between the mean VA of the P0 and
1 groups (P  .923 for preoperative data and P  .943 for
ostoperative data). The final VA improved by more than
wo lines in 54 (61.4%) of the 88 eyes without cataract
xtraction, with no statistically significant difference be-
ween the two positions (P  .999).
The results obtained for idiopathic MH closure accord-
ng to the size of the idiopathic MH were retrospectively
nalyzed. We found that in small MHs (less than 400 m
n diameter), the overall anatomic success rate was 98.6%
69/70): 97.0% (32/33) and 100.0% (37/37) for P0 and P1,
espectively (Figure 3). The difference between P0 and P1
n small idiopathic MHs was not significant (P  .47). On
he contrary, in large MHs (more than 400 m in
iameter), the overall anatomic success rate was 70/80
87.5%); 31/39 (79.5%); and 39/41 (95.1%) for P0 and P1,
espectively. The difference between P0 and P1 in large
diopathic MHs was significant (P  .045). Whatever the
osition, the difference between small (400 m) and
arge idiopathic MHs (400 m) was significant (P 
IGURE 6. Visual acuity (VA) changes after idiopathic MH
urgery according to the type of surgical procedure: single MH
urgery or MH surgery combined with cataract extraction and
ntraocular lens. Preop VA: preoperative visual acuity; Postop
A: postoperative visual acuity.011) (Figures 4 and 5). C
POSITIONING AFTER MACUOL. 146, NO. 1The 62 combined surgeries for idiopathic MH and
hacoemulsification were also analyzed. There were 30 and
2 eyes in the P0 and P1 groups, respectively. There were
8 idiopathic MHs smaller than 400 m and 34 idiopathic
Hs larger than 400 m. The three anatomic failures were
n the subgroup of patients with idiopathic MHs larger
han 400 m who adopted the seated position. The
natomic success rate was 96.8% for combined surgery vs
9.8% for a single procedure (P  .124). The functional
esults showed VA means increasing from 1.1 to 0.47 and
he final VA improved by two lines or more in 55 (89%)
f the 62 eyes with combined surgery (Figure 6).
We observed 11 anatomic failures in this study: three
atients refused another treatment and eight underwent a
econd procedure with total FAE and intraocular gas
amponade, leading to anatomic success in five of them.
Severe complications were 12 RDs, four and eight in the
0 and P1 groups (P  .373), respectively. Four RDs were
nferior, four RDs were superior, and four RDs were total,
wo with vitreoretinal proliferation. RDs occurred from
ne to 85 days after surgery (45  30). Eight were treated
uccessfully with one operation. Four needed from one to
wo additional surgeries. There was no endophthalmitis
nd no chronic elevation of IOP.
DISCUSSION
ROPER IDIOPATHIC MH MANAGEMENT REQUIRES THAT
he edges of the hole be kept dry with the gas tamponade
nd the closure of the hole be achieved within a few days.
Intraocular gas tamponade has two main properties: surface
ension and buoyancy.22,25 Buoyancy is related to density and
urface tension is related to the viscosity of the tamponade
roduct. The surface tension is constant around the entire
nterface with the retina. The buoyant force is maximal at the
pex of the bubble depending on gravity and the depth of the
amponade product, which is why the postoperative position
fter RD is important: buoyancy can move the subretinal fluid
o reattach the retina. After idiopathic MH surgery, buoyant
orce is of minor interest, since the most important feature is
o obturate the hole by keeping its edges dry using the surface
ension of the gas bubble, independent of buoyancy. There-
ore patients are prohibited from looking up, thus allowing a
ermanent contact between the gas and the edges of the hole.
inally, the position of the eye after intraocular tamponade
hould not influence the surface tension around the MH if
he volume of intraocular gas is sufficient.
The length of time needed to heal the MH remains
nknown, mainly because the macula is difficult to see and an
CT cannot be performed through the gas. Using silicone oil
or the intraocular tamponade provides better visualization of
he fundus, and an OCT can be performed in the early
ostoperative period: in this condition, it was shown than a
H could heal as rapidly as one day after surgery.21,22,26losure of MHs with silicone oil tamponade is another




































































































rgument for giving a secondary role to the buoyant force
buoyancy is less with silicone oil than with gas). After
eakage of a vitrectomy port resulting in a 20% intraocular gas
ubble at day 1, Sato observed that OCT could be performed
nder the bubble and assessed the closure of stage 2 MH
ithin the first 48 hours of the procedure.27 These findings
ave led some authors to propose a shorter positioning time
fter surgery: no difference was observed between a three-day
nd a seven-day positioning time (success rates: 87.5% vs
3.1%, P  .05),28 and a success rate of 91% was obtained
ith a four-day positioning time and air tamponade.29 Finally,
here is growing evidence that the initial size of the MH is
orrelated with the time of closure and the success rate.30–32
The anatomic results of our study are in agreement with
he literature, with 92.7% MH closure after a single proce-
ure.11,14,29 The anatomic success rate of the P0 group
87.5%) is similar to other studies without the face-down
osition (success rates: 80% and 86% using silicone oil
amponade20,22 and 79% and 87.5% using gas23). However,
n our study, considering all cases, the difference in anatomic
esults between the face-down position and seated position
as significant. The visual results were good, with 61.4% of
A improvement by more than two lines. The final VA
ecovery seems to depend on the baseline VA, so we
ecommend prompt surgical treatment for idiopathic MH
hile VA remains good, as other authors have suggest-
d.23,29–31 Poor functional results were associated with severe
Ds (four RDs required iterative surgeries for a total number
f 150 eyes) or other causes of low VA (e.g., age-related
acular degeneration). It is interesting to note that the rate
f RDs in this study was higher than anatomic failures. This
nding highlights the importance of detecting retinal breaks
nd RDs in order to treat them before, during, or after surgery.
ndeed, the patient must be fully informed of this potential
omplication.33
Nevertheless, if we consider only small idiopathic MHs
400 m), our study found no significant difference
etween the two postoperative positions. There was only
ne anatomic failure among 70 idiopathic MHs smaller
han 400 m, and this very good prognosis should lead to
less strict recommendation in terms of postoperative
ositioning. Older patients, for example, could adopt a
ore comfortable postoperative position if their idiopathic
H is small.
In our series, the ILM was systematically peeled without
ye, a technique that is still under debate.5 We believe
hat it could lead to better healing of the MH and prevent
ate reopening.32 It is interesting to compare the results of
ur study with a recent retrospective series investigating
he relationship between the size of the idiopathic MH andpotential benefit of ILM peeling.34 The authors con- c
AMERICAN JOURNAL OF32luded that ILM peeling could be advantageous for MHs
arger than 400 m and may be unnecessary for smaller
diopathic MHs. These results suggest two different types
f idiopathic MH management: minimal treatment for
mall idiopathic MHs without ILM peeling and without
he face-down position and more consequential treatment
or large MHs (400 m).
The use of different gases depending on the size of the hole
an be discussed. We arbitrarily chose different gases accord-
ng to the size of the idiopathic MH, using longer-acting gas
or larger MHs. It is probable that the important factor is the
nitial contact with the edges of the hole rather than the
uration of the internal tamponade. As the bubbles in the
resent study were always nearly complete, the influence of
he type of gas was probably negligible. However, the use of
ifferent gases in our procedure remains a possible bias.
We acknowledge several other limitations to our study:
early half of the surgeries were combined with a cataract
xtraction in this study, a potential bias. Some authors
howed that during the combined procedure, vitrectomy
an be enlarged, allowing a larger gas tamponade.35 There-
ore, we could expect a higher rate of idiopathic MH
losure in combined surgery than in a single procedure
96.8% vs 89.8%) in our study (P  .12). However, since
he distribution of combined surgery was similar in both
roups this bias seems acceptable. The criterion analyzed
n our study was the postoperative patient position. It was
ifficult to closely monitor that proper positioning was
espected for the length of time recommended. Therefore,
atients were provided with careful explanations after
urgery. We found a significant statistical difference be-
ween the two positions with a preference for the face-
own position. However, we did not find any difference
hen the idiopathic MH was smaller than 400 m. This
ould be caused by the lack of power in the subgroup
nalysis. However, a noninferiority trial would require
232 eyes, which is unfeasible. The duration of the
ostoperative position was arbitrarily defined as five days.
he literature describes a wide range for this duration and
he exact time needed is still under debate, although the
ccepted duration is more than seven days.28
In conclusion, postoperative positioning influences the
ate of MH closure. However, the good prognosis and the
uick closure of idiopathic MHs smaller than 400 m
robably make the face-down position unnecessary in
elected patients. On the contrary, patients with idiopathic
Hs larger than 400 m should ideally retain the face-
own position, which is still considered the standard of
are. Further prospective studies considering not only the
ositioning but also the size of the MH are warranted to
onfirm these results.HE AUTHORS INDICATE NO FINANCIAL SUPPORT OR FINANCIAL CONFLICT OF INTEREST. INVOLVED IN DESIGN AND
onduct of study (A.G., P.O.L., J.P.B., C.C.-G.); collection, analysis, and interpretation of the data (A.G., L.M., P.O.L., N.J., I.H., J.P.B., C.C.-G.); and










urgundy, France. The registration number of our trial is ISRCTN21076960 and the registration information is available at http://www.controlled-
rials.com/ISRCTN21076960.
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